0

<< Management Of Acute Asthma In The Pediatric Patient: An Evidence-Based Review

References

TOC Will Appear Here

References

References

Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of subjects. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.

To help the reader judge the strength of each reference, pertinent information about the study, such as the type of study and the number of patients in the study will be included in bold type following the references, where available. The most informative references cited in this paper, as determined by the author, will be noted by an asterisk (*) next to the number of the reference.

  1. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. New estimates for asthma tracked. Released October 5, 2001. Available at: http://www.cdc.gov/nchs/ pressroom/01facts/asthma.htm. Accessed January 15, 2013. (Epidemiologic report)
  2. Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001 -2010. NCHS data brief, no 94. Hyattsville, MD: National Center for Health Statistics. 2012. Available at: http://www.cdc.gov/nchs/data/databriefs/db94.pdf. Accessed January 15, 2013. (Epidemiologic report)
  3. Elias JA, Lee CG, Zheng T, et al. New insights into the pathogenesis of asthma. J Clin Invest. 2003;111(3):291-297. (Basic science review)
  4. O’Byrne PM, Inman MD. Airway hyperresponsiveness. Chest. 2003;123(3 Suppl):411S-416S. (Basic science review)
  5. Qureshi F. Management of children with acute asthma in the emergency department. Pediatr Emerg Care. 1999;15(3):206- 214. (Review)
  6. Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis. 1991;144:151. (Basic science review)
  7. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999;17:255-281. (Basic science review)
  8. Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol. 1996;97:1252. (Basic science review)
  9. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789- 815. (Basic science review)
  10. Hanson IC, Shearer WT. Bronchiolitis. In: Oski’s Pediatrics: Principles and Practice, 4th ed. McMillan JA, Feigin RD, DeAngelis C, et al (eds). Lippincott Williams & Wilkins, Philadelphia 2006. 1391. (Textbook)
  11. Weinberger M, Mutasim A. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics. 2007;120:855-864. (Review)
  12. Slaughter MC. Not quite asthma: differential diagnosis of dyspnea, cough, and wheezing. Allergy Asthma Proc. 2007;28(3):271-281. (Review)
  13. Abu-Hasan M, Tannous B, et al. Exercise-induced dyspnea in children and adolescents: if not asthma then what? Ann Allergy Asthma Immunol. 2005;94(3):366-371. (Retrospective review; 142 patients)
  14. Grisaru-Soen, Komisar O, Aizenstein O, et al. Retropharyngeal and parapharyngeal abscess in children—epidemiology, clinical features and treatment. Int J Pediatr Otorhinolaryngol. 2010;74(9):1016-1020. (Retrospective chart review; 39 patients)
  15. Bertelli L, Gentili A, Modolon C, et al. A foreign body aspiration in a preschool child mimicking a multitrigger wheezing: a case report and review of the literature. Pediatr Emerg Care. 2012;28(12):1382-1384. (Case report and review)
  16. Bahrainwala AH, Simon MR. Wheezing and vocal cord dysfunction mimicking asthma. Curr Opin Pulm Med. 2001;7(1):8-13. (Review)
  17. McFadden ER Jr, Zawadski DK. Vocal cord dysfunction masquerading as exercise-induced asthma; a physiologic cause for ”choking” during athletic activities. Am J Respir Crit Care Med. 1996;153(3):942-947. (Review)
  18. Linz AJ. The relationship between psychogenic cough and the diagnosis and misdiagnosis of asthma: a review. J Asthma. 2007;44(5):347-355. (Review)
  19. Koh YY, Chae SA, Min KU. Cough variant asthma is associated with a higher wheezing threshold than classic asthma. Clin Exp Allergy. 1993;23(8):696-701. (Prospective case-control series; 44 patients)
  20. Chang AB. Cough, cough receptors, and asthma in children. Pediatr Pulmonology. 1999;28(1):59-70. (Review)
  21. Johnson D, Osborn LM. Cough variant asthma: a review of the clinical literature. J Asthma. 1993;28(2):85-90. (Review)
  22. Fijumura M, Ogawa H, Nishizawa, et al. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor to asthma? Thorax. 2003;58(1):14-18. (Retrospective chart review; 137 patients)
  23. Niimi A, Matsumoto H, Minakuchi M, et al. Airway remodelling in cough-variant asthma. Lancet. 2000;356(9229):564- 565. (Prospective case-control series; 46 subjects)
  24. Delbridge T, Domeier R, Key CB. Prehospital asthma management. Prehosp Emerg Care. 2003;7(1):42-47. (Review)
  25. Camargo CA. EMS management of asthma exacerbations. Prehosp Emerg Care. 2006;10(4):418-429. (Review)
  26. Richmond NL, Silverman RA. Ksick M, et al. Out-of-hospital administration of albuterol for asthma by basic life support providers Acad Emerg Med. 2005;12(5):396-403. (Prospective cohort study; 3351 patients)
  27. Mitchell I, Tough SC, Semple LK, et al. Near-fatal asthma: a population-based study of risk factors. Chest. 2002;121(5):1407-1413. (Case-control study; 45 patients)
  28. National Heart, Blood, and Lung Institute; National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; 2007. (Clinical guideline)
  29. Pollack CV Jr, Pollack ES, Multicenter Airway Research Collaboration Investigators, et al. A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute obasthma. Arch Pediatr Adolesc Med. 2002;156(9):934-940. (Prospective cohort study; 275 patients)
  30. Keogh KA, Macarthur C, Parkin PC, et al. Predictors of hospitalization in children with acute asthma. J Pediatr. 2001;139(2):273-277. (Prospective cohort study; 278 patients)
  31. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J. 1994;7(9):1602-1609. (Case-control study; 784 patients)
  32. Akinbami LJ. The State of childhood asthma, United States, 1980-2005. Advance data from vital and health statistics; no 381, Hyattsville, MD: National Center for Health Statistics. 2006. (Epidemiologic report)
  33. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics. 2002;110(2 Pt 1):315-322. (Epidemiologic report)
  34. Martin AJ, Campbell DA, Gluyas PA, et al. Characteristics of near-fatal asthma in childhood. Pediatr Pulmonol. 1995;20(1):1-8. (Retrospective review; 30 patients)
  35. Belessis Y, Dixon S, Thomsen A, et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol. 2004;37(3):201-209. (Case-control study; 141 patients)
  36. Geelhoed GC, Landau LI, LeSouëf PN. Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma. Annals of Emerg Med. 1994;23(6)1236-1241. (Prospective observational double-blind study; 280 patients)
  37. Jenkins HA, Cherniack R, Szefler SJ, et al. A comparison of the clinical characteristics of children and adults with severe asthma. Chest. 2003;124(4):1318-1324. (Retrospective analysis of prospective data; 275 patients)
  38. Yamamoto LG, Wiebe RA, Rosen LM, et al. Oxygen saturation changes during the pediatric emergency department treatment of wheezing. Am J Emerg Med. 1992;10(4):274-284. (Prospective cohort; 7381 patients)
  39. Mehta SV, Parkin PC, Stephens D, et al. Oxygen saturation as a predictor of prolonged, frequent bronchodilator therapy in children with acute asthma. J Pediatr. 2004;145(5):641-645. (Prospective cohort study; 273 patients)
  40. Keahey L, Bulloch B, Multicenter Asthma Research Collaboration (MARC) Investigators, et al. Initial oxygen saturation as a predictor of admission in children presenting to the emergency department with acute asthma. Ann Emerg Med. 2002;40(3):300-307. (Prospective cohort study; 1184 patients)
  41. Yamamoto LG, Wiebe RA, Anaya C, et al. Pulse oximetry and peak flow as indicators of wheezing severity in children and improvement following bronchodilator treatments. Am J Emerg Med. 1992;10(6):519-524. (Prospective cohort study; 785 patients)
  42. Murphy S, Kelly HW. Pediatric Asthma. New York: Marcel Dekker, Inc., 1999;242. (Textbook)
  43. VanderWindt D. Promises and pitfalls in the evaluation of pediatric asthma scores. J Pediatr. 2000;137(6):744-746. (Editorial)
  44. Carroll CL, Sekaran AK, Lerer TJ, et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol. 2005;94(3):355- 359. (Cohort study; 30 patients)
  45. Smith SR, Baty JD, Hodge D 3rd. Validation of the pulmonary score: an asthma severity score for children. Acad Emerg Med. 2002;9(2):99-104. (Prospective cohort study; 46 patients)
  46. VanderWindt DA, Nagelkerke AF, Bouter LM, et al. Clinical scores for acute asthma in pre-school children. A review of the literature. J Clin Epidemiol. 1994;47(6):635-646. (Review)
  47. Gorelick MH, Stevens MW, Schultz TR, et al. Performance of a novel clinical score, the Pediatric Asthma Severity Score (PASS), in the evaluation of acute asthma. Acad Emerg Med. 2004;11(1):10-18. (Prospective cohort study; 1221 patients)
  48. Ducharme FM, Chalut D, Plotnick L, et al. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr. 2008;152(4):476-480. (Prospective cohort study; 254 patients)
  49. Arnold DH, Saville BR, Wang W, et al. Performance of the Acute Asthma Intensity Research Score (AAIRS) for acute asthma research protocols. Ann Allergy Asthma Immunol. 2012;109(1):78-79. (Prospective cohort; 661 patients)
  50. Gentile NT, Ufberg J, Barnum M, et al. Guidelines reduce xray and blood gas utilization in acute asthma. J of Emerg Med. 2003; 21(6):451-453. (Review)
  51. Moses JM, Alexander JL, Agus MS. The correlation and level of agreement between end-tidal and blood gas PCO2 in children with respiratory distress: a retrospective analysis. BMC Pediatr. 2009:9(20). (Retrospective review; 62 patients)
  52. Casati A, Gallioli G, Scandroglio M, et al. Accuracy of end-tidal carbon dioxide monitoring using the NBP-75 microstream capnometer. A study in intubated ventilated and spontensously breathing patients. Eur J Anaesthesiol. 2000;17(10):622-626. (Prospective crossover study; 20 patients)
  53. Langhan ML, Zonfrillo MR, Spiro DM. Quantitative end-tidal carbon dioxide in acute exacerbations of asthma. J Pediatr. 2008:152(6):829-832. (Prospective case-control observational study; 174 patients)
  54. Moses JM, Alexander JL, Agus MS. The correlation and level of agreement between end-tidal and blood gas PCO2 in children with respiratory distress: a retrospective analysis. BMC Pediatr. 2009:9(20). (Retrospective review; 62 patients)
  55. Kanis J, Lovell J, Bowman M, et al. Focused assessment of patients with asthma in the emergency department. Clinical Pediatr. 2011;50(6):529-534. (Retrospective cross-sectional descriptive study; 156 patients)
  56. Carruthers DM, Harrison BD. Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax. 1995;50(2):186-188. (Prospective cohort study; 89 patients)
  57. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest. 2004;125(3):1081-1102. (Review)
  58. Lugogo NL, MacIntyre NR. Life-threatening asthma: pathophysiology and management. Resp Care. 2008;53(6):726-739. (Review)
  59. Tsai SL, Crain EF, Silver EJ, et al. What can we learn from chest radiographs in hypoxic asthmatics? Pediatr Radiol. 2002;32(7):498-504. (Prospective cohort study; 445 patients)
  60. Roback MG, Dreitlein DA. Chest radiograph in the evaluation of first-time wheezing episodes: review of current clinical practice and efficacy. Pediatr Emerg Care. 1998;14(3):181- 184. (Retrospective chart review; 298 patients)
  61. Mahabee-Gittens EM, Bachman DT, Shapiro ED, et al. Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezing. Clin Pediatr (Phila). 1999;38(7):395-399. (Retrospective chart review; 270 patients)
  62. Matthews B, Shah S, Cleveland RH, et al. Clinical predictors of pneumonia among children with wheezing. Pediatrics. 2009;124(1):e29-e36. (Prospective cohort study; 526 patients)
  63. Mahabee-Gittens EM, DiGiulio GA, Gonzalez del Rey JA, et al. Are pediatric ED physicians blowing off peak expiratory flows? Am J Emerg Med. 2000;18(3):352-353. (Letter to editor)
  64. Callahan KA, Panter TH, Hall TM, et al. Peak flow monitoring in pediatric asthma management: a clinical practice column submission. J Pediatric Nursing. 2010;25:12-17. (Review)
  65. Gorelick MH, Stevens MW, Schultz T, et al. Difficulty in obasthma. taining peak expiratory flow measurements in children with acute asthma. Pediatr Emerg Care. 2004;20(1):22-26. (Prospective cohort study; 456 patients)
  66. Scarfone RJ, Capraro GA, Zorc JJ, et al. Demonstrated use of metered-dose inhalers and peak flow meters by children and adolescents with acute asthma exacerbations. Arch Pediatr Adolesc Med. 2002;156(4):378-383. (Prospective cohort study; 407 patients)
  67. Eid N, Yandell B, Howell L, et al. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics. 2000;105(2):354-358. (Prospective cohort; 244 patients)
  68. Lexi-Comp OnlineTM, Pediatric and Neonatal Lexi-Drugs OnlineTM. Hudson, Ohio: Lexi-Comp, Inc.; Accessed April 1, 2013.
  69. Katz RW, Kelly HW, Crowley MR, et al. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics. 1993;92(5):666-669. (Prospective case series; 19 patients)
  70. Krebs SE, Flood RG, Peter JR, et al. Evaluation of a highdose continuous albuterol protocol for treatment of pediatric asthma in the emergency department. Ped Emerg Care. 2013;29(2):191-196. (Retrospective chart review; 766 patients)
  71. Habashy D, Lam LT, Browne GJ. The administration of beta 2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey. Eur J Emerg Med. 2003;10(3):219-224. (Cross-sectional survey; 33 hospitals)
  72. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006(2). (Systematic review)
  73. Schuh S, Johnson DW, Stephens D, et al. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr. 1999;135(1):22-27. (Randomized double-blind study; 90 patients)
  74. Amirav I, Newhouse MT. Metered-dose inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review. Arch Pediatr Adolesc Med. 1997;151(9):876-882. (Review)
  75. Benito-Fernández J, González-Balenciaga M, Capapé-Zache S, et al. Salbutamol metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department. Pediatr Emerg Care. 2004;20(10):656- 659. (Retrospective/prospective cohort study; 580 patients)
  76. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care. 2008;53(6):699-725. (Review)
  77. Hess DR. Nebulizers: principles and performance. Respir Care 2000;46(6):609-622. (Review)
  78. Sabato K, Ward P, Hawk W, et al. Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Resp Care. 2011;56(6):761-770. (Prospective randomized controlled trial; 149 patients)
  79. Scarfone RJ, Friedlaender EY. Beta 2-agonists in acute asthma: the evolving state of the art. Pediatr Emerg Care. 2002;18(6):442-427. (Review)
  80. Schuh S, Reider MJ, Canny G, et al. Nebulized albuterol in acute childhood asthma: comparison of two doses. Pediatrics. 1990;86(4):509-513. (Randomized double-blind study; 33 patients)
  81. McFadden ER Jr, Strauss L, Hejal R, et al. Comparison of two dosage regimens of albuterol in acute asthma. Am J Med. 1998;105(1):12-17. (Prospective sequential study; 160 patients)
  82. Titus MO, Eady M, King L, et al. Clinical Pediatr. 2012;51(12):1150-1154. (Prospective nonblinded convenience sample study; 159 patients)
  83. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev. 2003;(4) (Systematic review)
  84. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21(10):1479-1486. (Prospective randomized study; 17 patients)
  85. Barnes PJ. Treatment with (R)-albuterol has no advantage over racemic albuterol. Amer J Resp Crit Care Med. 2006;174:969-972. (Editorial)
  86. Hardasmalani MD, DeBari V, Bithoney WG, et al. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care. 2005;21(7):415-419. (Prospective randomized double-blind study; 70 patients)
  87. Zhang X, Zhu F, Olszewski MA, et al. Effects of enantiomers of beta 2-agonists on ach release and smooth muscle contraction in the trachea. Am J Physiol. 1998;274(1 Pt 1):L32-L38. (Basic science)
  88. Mitra S, Ugur M, Ugur O, et al. (S)-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol. 1998;53(3):347-354. (Basic science)
  89. Ralston ME, Euwema MS, Knecht KR, et al. Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. J Emerg Med. 2005;29(1):29-35. (Randomized controlled study; 140 patients)
  90. Qureshi F, Zaritsky A, Welch C, et al. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med. 2005;46(1):29-36. (Prospective randomized double-blind study; 129 patients)
  91. Rubin BK, Haynes JM. Myths, misunderstandings, and dogma in respiratory care. Resp Care. 2012;57(8):1314-1324. (Review)
  92. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta 2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2000;(4). (Systematic review)
  93. Aaron SD. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review. J Asthma. 2001;38(7):521-530. (Systematic review)
  94. Qureshi F, Pestian J, Davis P, et al. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med. 1998;339(15):1030-1035. (Randomized double-blind placebo-controlled study; 434 patients)
  95. Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med. 2001;155(12):1329-1334. (Randomized trial; 80 patients)
  96. Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest. 2002;121(6):1977-1987. (Review)
  97. Bone WD, Amundson DE. An unusual case of severe anaphylaxis due to ipratropium bromide inhalation. Chest. 1993;103(3):981-982. (Case report)
  98. Ramirez DA, Bahna SL. Food and hypersensitivity by inhalation. Clin Mol Allergy. 2009;7(4). (Review)
  99. Bjornson C, Russell KF, Vandermeer B, et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2011; http://onlinelibrary.wiley.com/doi/10.1002/14651858. CD006619.pub2/abstract
  100. Schuh S. Update on management of bronchiolitis. Curr Opin Pediatr. 2011;23(1):110-114. (Review)
  101. Wiebe K, Rowe BH. Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review. CJEM. 2007;9(4):304-308. (Review)
  102. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta 2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials. Am J Emerg Med. 2006;24(2):217-222. (Meta-analysis)
  103. Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med. 2000;7(10):1097-1103. (Randomized double-blind study; 120 patients)
  104. Lin YZ, Hsieh KH, Chang LF, et al. Terbutaline nebulization and epinephrine injection in treating acute asthmatic children. Pediatr Allergy Immunol. 1996;7(2):95-99. (Prospective cohort study; 90 patients)
  105. Travers AH, Rowe BH, Barker S, et al. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis. Chest. 2002;122(4):1200-1207. (Meta-analysis)
  106. Bogie AL, Towne D, Luckett PM, et al. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care. 2007;23(6):355-361. (Prospective randomized double-blind placebo-controlled study; 49 patients)
  107. Travers A, Jones AP, Kelly K, et al. Intravenous beta 2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev. 2001, Issue 1. Art. No.: CD002988. (Systematic review and meta-analysis)
  108. Stephanopoulos DE, Monge R, Schell KH, et al. Continuous intravenous terbutaline for pediatric status asthmaticus. Crit Care Med. 1998;26(10):1744-1748. (Retrospective review; 18 patients)
  109. Chiang VW, Burns JP, Rifai N, et al. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr. 2000;137(1):73- 77. (Prospective cohort study; 3 patients)
  110. Chiang VW, Burns JP, Rifai N, et al. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. Journal Pediatr. 1998;137(1):73-77. (Prospective cohort; 29 patients)
  111. Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med. 2006;47(6):559-563. (Retrospective chart review; 220 patients)
  112. Younger RE, Gerber PS, Herrod HG, et al. Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics. 1987;80(2):225-230. (Randomized placebocontrolled study; 49 patients)
  113. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med. 2003;139(5 Pt 1):359-370. (Review)
  114. FitzGerald JM, Becker A, Canadian Asthma Exacerbation Study Group, et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax. 2004;59:550–556. (Randomized double-blind placebo-controlled study; 98 patients)
  115. Harrison TW, Oborne J, Newton S, et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363:271-275. (Randomized controlled study; 390 patients)
  116. Volovitz B, Nussinovitch M, Finkelstein Y, et al. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin Pediatr (Phila). 2001;40(2):79-86. (Quasi-randomized crossover study; 100 patients)
  117. Oborne J, Mortimer K, Hubbard RB, et al. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations. Am J Respir Crit Care Med. 2009;180(7):598-602. (Randomized double-blind placebo-controlled study; 403 patients)
  118. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir Med. 2007;101(4):685-695. (Review)
  119. Schramm CM, Carroll CL. Advances in treating acute asthma exacerbations in children. Curr Opin Pediatr. 2009;21(3):326- 332. (Review)
  120. Scarfone RJ, Fuchs SM, Nager AL, et al. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993;92(4):513-518. (Randomized double-blind placebo-controlled study; 75 patients)
  121. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;(1). (Systematic review)
  122. Zemek R, Plint A, Osmond MH, et al. Triage nurse initiation of corticosteroids in pediatric asthma is associated with improved emergency department efficiency. Pediatrics. 2012;129(4):671-680. (Prospective time-series controlled trial; 644 patients)
  123. Rowe BH, Spooner CH, Ducharme FM, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2007;(3). (Systematic review)
  124. Butler K, Cooper WO. Adherence of pediatric asthma patients with oral corticosteroid prescriptions following pediatric emergency department visit or hospitalization. Pediatr Emerg Care. 2004;20(11):730-735. (Survey; 161 patients)
  125. Gordon S, Tompkins T, Dayan PS. Randomized trial of single-dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatr Emerg Care. 2007;23(8):521-527. (Prospective randomized study; 88 patients)
  126. Gries DM, Moffitt DR, Pulos E, et al. A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. J Pediatr. 2000;136(3):298-303. (Prospective randomized blinded study; 32 patients)
  127. Altamimi S, Robertson G, Jastaniah W, et al. Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. Pediatr Emerg Care. 2006;22(12):786-793. (Prospective randomized double-blind study; 134 patients)
  128. Chang AB, Clark R, Sloots TP, et al. A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Med J Aust. 2008;189(6):306-310. (Prospective randomized controlled study; 201 patients)
  129. Qureshi F, Zaritsky A, Poirier MP. Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr. 2001;139(1):20-26. (Prospective randomized study; 533 patients)
  130. Greenberg RA, Kerby G, Roosevelt GE. A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. Clin Pediatr. 2008;47(8):817-823. (Prospective randomized placebocontrolled double-blind study; 89 patients)
  131. Chub-Uppakarn S, Sangsupawanich P. A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/ kg for the treatment of moderate to severe croup. Int J Pediatr Otorhinolaryngol. 2007;71(3):473-477. (Prospective randomized controlled study; 21 patients)
  132. Fifoot AA, Ting JY. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emerg Med Australas. 2007;19:51-58. (Prospective double-blind randomized controlled study; 99 patients)
  133. Geelhoed G, Macdonald W. Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/ kg. Pediatr Pulmonol. 1995;20:362-368. (Proespective doubleblind randomized controlled study; 120 patients)
  134. Barnett PL, Caputo GL, Baskin M, et al. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med. 1997;29(2):212-217. (Randomized double-blind controlled study; 49 patients)
  135. Carter E, Cruz M, Chesrown S, et al. Efficacy of intravenously administered theophylline in children hospitalized with severe asthma. J Pediatr. 1993;122(3):470-476. (Prospective randomized placebo-controlled double-blind parallel group study; 21 patients)
  136. DiGiulio GA, Kercsmar CM, Krug SE, et al. Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr. 1993;122(3):464-469. (Prospective randomized placebo-controlled double-blind study; 29 patients)
  137. Strauss RE, Wertheim DL, Bonagura VR, et al. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics. 1994;93(2):205-210. (Prospective randomized double-blind placebo-controlled study; 38 patients)
  138. Nuhoğlu Y, Dai A, Barlan IB, et al. Efficacy of aminophylline in the treatment of acute asthma exacerbation in children. Ann Allergy Asthma Immunol. 1998;80(5):395-398. (Prospective randomized double-blind placebo-controlled study; 38 patients)
  139. Wheeler DS, Jacobs BR, Kenreigh CA, et al. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care Med. 2005;6(2):142-147. (Prospective randomized controlled trial; 40 patients)
  140. Fotinos C, Dodson S. Clinical inquiries. Is there a role for theophylline in treating patients with asthma? J Fam Pract. 2002;51(9):744. (Review)
  141. Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child. 1998;79(5):405-410. (Randomized double-blind placebocontrolled study; 163 patients)
  142. Ream RS, Loftis LL, Albers GM, et al. Efficacy of IV theophylline in children with severe status asthmaticus. Chest. 2001;119(5):1480-1488. (Prospective randomized controlled study; 47 patients)
  143. Mitra A, Bassler D, Goodman K, et al. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev. 2005(2) (Systematic review)
  144. Goodman DC, Littenberg B, O’Connor GT, et al. Theophylline in acute childhood asthma: a meta-analysis of its efficacy. Pediatr Pulmonol. 1996;21(4):211-218. (Meta-analysis)
  145. Bien JP, Bloom MD, Evans RL, et al. Theophylline in acute childhood asthma: a meta-analysis of its efficacy. Pediatr Pulmonol. 1996;21(4):211-218. (Meta-analysis)
  146. Dalabih AR, Bondi SA, Harris ZL, et al. Aminophylline infusion for status asthmaticus in the pediatric critical care unit setting is independently associated with increased length of stay and time for symptom improvement. Pulm Pharmacol Ther. Available online 19 March 2013. (Retrospective chart review; 96 patients)
  147. Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med. 2000;36(6):572-578. (Randomized double-blind placebo-controlled study; 54 patients)
  148. Rowe BH, Camargo CA Jr. The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulm Med. 2008;14(1):70-76. (Review)
  149. Markovitz B. Does magnesium sulphate have a role in the management of paediatric status asthmaticus? Arch Dis Child. 2002;86(5):381-382. (Review)
  150. Rowe BH, Bretzlaff JA, Bourdon C, et al. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med. 2000;36(3):181-190. (Literature review)
  151. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med. 2000;154(10):979-983. (Prospective double-blind placebo-controlled study; 30 patients)
  152. Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr. 1996;129(6):809-814. (Prospective double-blind placebocontrolled study; 31 patients)
  153. Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child. 2005;90(1):74-77. (Meta-analysis)
  154. Glover ML, Machado C, Totapally BR. Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing. J Crit Care. 2002;17(4):255-258. (Retrospective chart review)
  155. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma systematic reviews and meta-analysis. Emerg Med J. 2007:24(12);823-830. (Review)
  156. Pabon H, Monem G, Kissoon N. Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus. Pediatr Emerg Care. 1994;10(4):200-203. (Case report)
  157. Coates AL, Leung K, Vecellio L, et al. Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department. Resp Care. 2011:56 (3):314-318. (Device comparison)
  158. Gallegos-Solorzano MC, Perez-Padilla R, Hemandez- Zenteno RJ. Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department. Pulm Pharmacol Ther. 2010;23(5):432- 437. (Prospective double-blind placebo-controlled study; 30 patients)
  159. Blitz M, Blitz S, Beasley R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2009(3). (Systematic review)
  160. Hill J, Britton J. Dose-response relationship and timecourse of the effect of inhaled magnesium sulphate on airflow in normal and asthmatic subjects. Br J Clin Pharmacol. 2012;40(6):539-544. (Prospective randomized doubleblind study; 39 patients)
  161. Villeneuve EJ, Zed PJ. Nebulized magnesium sulfate in the management of acute exacerbations of asthma. Ann Pharmacother. Villeneuve, 2006;40(6):1118-1124. (Meta-analysis)
  162. Peters-Golden M, Henderson WR. Leukotrienes. N Engl J Med. 2007;357(18):1841-1854. (Review)
  163. Johnston NW, Mandhane PJ, Dai J, et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics. 2007;120(3):e702-e712. (Prospective double-blind placebo-controlled study; 194 patients)
  164. Drazen JM, Israel E, O’Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999;340(3):197-206. (Review)
  165. Camargo CA, Gurner DM, Smithline HA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol. 2010;125(2):374-380. (Prospective randomized double-blind study; 583 patients)
  166. Morris CR, Becker AB, Piñeiro A, et al. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol. 2010;104(2):161-171. (Randomized double-blind placebocontrolled study; 276 patients)
  167. Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;16(5). (Systematic review)
  168. White PF, Way WL, Trevor AJ. Ketamine--its pharmacology and therapeutic uses. Anesthesiology. 1982;56(2):119-136. (Review)
  169. Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med. 2005;46(1):43-50. (Prospective double-blind placebo-controlled study; 68 patients)
  170. Denmark TK, Crane HA, Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med. 2006;30(2):163-166. (Case report)
  171. Petrillo TM, Fortenberry JD, Linger JF, et al. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma. 2001;38(8):657-664. (Cohort study; 10 patients)
  172. Shlamovitz GZ, Hawthorne T. Intravenous ketamine in dissociating dose as a temporizing measure to avoid mechanical ventilation in adult patient with severe asthma exacerbation. J Emerg Med. 2011;41(5):492-494. (Case report)
  173. Kim G, Green SM, Denmark TK, et al. Ventilatory response during dissociative sedation in children: a pilot study. Acad Emerg Med. 2003;10(2):140-145. (Prospective observational case series; 20 patients)
  174. Krauss B, Green SM. Procedural sedation and analgesia in children. Lancet. 2006;367(9512):766-780. (Review)
  175. Corssen G, Little SC, Tavakoli M. Ketamine and epilepsy. Anesthes Analg. 1974;53(2):319-335. (Prospective case-control series; 30 patients)
  176. Jolly T, McLean HS. Use of ketamine during procedural sedation. J Infusion Nursing. 2012;35(6):377-382. (Review)
  177. Wathen JE, Roback MG, Mackenzie T, et al. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled emergency department trial. Ann Emerg Med. 2000;36(6):579-588. (Prospective double-blind randomized controlled study; 266 patients)
  178. Green SM, Krauss B. Clinical practice guideline for emergency department ketamine dissociative sedation in children. Ann Emerg Med. 2004;44:460-471. (Clinical practice guideline)
  179. L’Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med. 1987;16(5):568-571. (Case report)
  180. Rock MJ, Reyes de la Rocha S, L’Hommedieu CS, et al. Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med. 1986;14(5):514-516. (Case report)
  181. Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med. 2005;6(2):204-211. (Review)
  182. Rivera ML, Kim TY, Stewart GM, et al. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am J Emerg Med. 2006;24(1):38-42. (Prospective randomized blinded controlled study; 41 patients)
  183. Kim IK, Phrampus E, Venkataraman S, et al. Helium/oxygen- driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics. 2005;116(5):1127-1133. (Randomized controlled single-blind trial; 30 patients)
  184. Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2006(4). (Systematic review)
  185. Beers SL, Abramo TJ, Bracken A, et al. Bi-level positive airway pressure in the treatment of status asthmaticus in pediatrics. Am J Emerg Med. 2007;25(1):6-9. (Retrospective review; 83 patients)
  186. Thill PJ, McGuire JK, Baden HP, et al. Noninvasive positivepressure ventilation in children with lower airway obstruction. Pediatr Crit Care Med. 2004;5(4):337-342. (Prospective randomized cross-over study; 20 patients)
  187. Carroll CL, Schramm CM. Noninvasive positive pressure ventilation for the treatment of status asthmaticus in children. Ann Allergy Asthma. 2006;96(3):454-459. (Retrospective review; 5 patients)
  188. Akingbola OA, Simakajornboon N, Hadley EF Jr, et al. Noninvasive positive-pressure ventilation in pediatric status asthmaticus. Pediatr Crit Care Med. 2002;3(2):181-184. (Case report; 3 patients)
  189. Ram FS, Wellington S, Rowe BH, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev. 2005(1). (Systematic review)
  190. Saharan S, Lodha R, Kabra SK. Management of status asthmaticus in children. Indian J Pediatr. 2010;77:1417-1423. (Review)
  191. Newth CJ, Rachman B, Patel N, et al. The use of cuffed versus uncuffed endotracheal tubes in pediatric intensive care. J Pediatr. 2004;144:333–337. (Cohort study; 860 patients)
  192. Kleinman ME et al. Pediatric Advanced Life Support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics. 2010;126(5):1361-1399. (Clinical practice guideline)
  193. Caro DA, Bush S. Pretreatment agents. In: Walls RM, Luten RC, Murphy MF, et al, eds. Manual of Emergency Airway Management. Philadelphia: Lippincott, Williams & Wilkins, 2000. (Textbook)
  194. Zelicof-Paul A, Smith-Lockridge A, Schnadower D, et al. Controversies in rapid sequence intubation in children. Curr Opinion Pediatr. 2005;17(3):355-362. (Review)
  195. Perry JJ, Lee JS, Sillberg VA, et al. Rocuronium versus succinylcholine for rapid sequence intubation. Cochrane Database Syst Rev. 2008;(2). (Systematic review)
  196. Leatherman JW. Mechanical ventilation for severe asthma. Respir Care. 2007;52(11):1460-1462. (Review)
  197. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med. 2003;168(7):740-759. (Review)
  198. Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med. 1996;24(3):379-380. (Review)
  199. Werner HA. Status asthmaticus in children: a review. Chest. 2001;119:1913-1929. (Review)
  200. Tobias JD, Garrett JS. Therapeutic options for severe, refractory status asthmaticus: inhalational anaesthetic agents, extracorporeal membrane oxygenation and helium/oxygen ventilation. Paediatr Anaesth. 1997;7(1):47-57. (Review)
  201. Jing Q, Yin T, Wan Y, et al. Interleukin-13 peptide kinoid vaccination attenuates allergic inflammation in a mouse model of asthma. Int J Mol Med. 2012:30(3);553-560. (Basic science)
  202. Gogate S, Katial R. Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophis and leukotriene E4. Curr Opin Allergy Clin Immunol. 2008;8(2):154-157. (Review)
  203. Pijnenburg MW, De Jongste JC. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy. 2008;38(2):246-259. (Review)
  204. Moeller A, Diefenbacher C, Lehmann A, et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol. 2008;121(3):705-709. (Cohort study; 391 patients)
  205. Rabinovitch N. Urinary leukotriene E4. Immunol Allergy Clin North Am. 2007;27(4):651-664. (Review)
  206. Kercsmar, C. Exhaled nitric oxide in the diagnosis and management of childhood asthma. Ther Adv Respir Dis. 2010;4(2):71-82. (Review)
  207. Fox H. Anti-IgE in severe persistent allergic asthma. Respirology. 2007;12 Suppl 3:S22-S28. (Review)
  208. Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 Step 4 treatment): INNOVATE. Allergy. 2005;60(3):309-316. (Prospective randomized double-blinded placebo-controlled study; 419 patients)
  209. Hendeles L, Sorkness CA. Anti-immunoglobulin E therapy with omalizumab for asthma. Ann Pharmacother. 2007;41(9):1397-1410. (Meta-analysis)
  210. Storms W, Bowdish M, Farrar JR. Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review. Allergy Asthma Proc. 2012;33(2):172-177. (Review)
  211. Hunt LW, Frigas E, Butterfield JH, et al. Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol. 2004;113(5):853. (Prospective randomized placebo-controlled study; 50 patients)
  212. Koyama N, Kinsella MG, Wight TN, et al. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. Circ Res. 1998;83(3):305. (Basic science review)
  213. Li CM, Newman D, Khosla J, et al. Heparin inhibits DNA synthesis and gene expression in alveolar type II cells. Am J Respir Cell Mol Biol. 2002;27(3):345. (Basic science review)
  214. Lever R, Page C. Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness. Pulm Pharmacol Ther. 2001;14(3):249. (Basic science review)
  215. Davies H, Olson L, Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev. 2000. (Systematic review)
  216. Evans DJ, Cullinan P, Geddes DM. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst Rev. 2001. (Systematic review)
  217. Fish JE, Peters SP, Chambers CV, et al. An evaluation of colchicine as an alternative to inhaled corticosteroids in moderate asthma. National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Am J Respir Crit Care Med. 1997;156(4 Pt 1):1165. (Prospective randomized double-blinded placebo-controlled study; 71 patients)
  218. Charous BL. Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma. Ann Allergy. 1990;65(1):53. (Prospective cohort study; 11 patients)
  219. Niggemann B, Leupold W, Schuster A, et al. Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma. Clin Exp Allergy. 1998;28(2):205. (Prospective randomized doubleblinded placebo-controlled study; 71 patients)
  220. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177(2):148. (Prospective randomized placebo-controlled study; 45 patients)
  221. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006;354(7):697. (Case-control study; 30 patients)
  222. Morjaria JB, Chauhan AJ, Babu KS, et al. The role of a soluble TNF alpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double-blind, randomised, placebo-controlled trial. Thorax. 2008;63(7):584-591. (Prospective randomized double-blinded placebo-controlled study; 39 patients)
  223. Denning DW, O’Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med. 2009;179(1):11- 18. (Cohort study; 58 patients)
  224. Matsuoka H, Niimi A, Matsumoto H, et al. Specific IgE response to trichophyton and asthma severity. Chest. 2009;135(4):898-903. (Case-control study; 372 patients)
  225. Vicencio AG, Santiago MT, Tsirilakis K, et al. Fungal sensitization in childhood persistent asthma is associated with disease severity. Pediatr Pulmonol. 2013 Feb 8. Epub ahead of print. (Prospective cross-sectional study; 64 patients)
  226. Engler RJ, With CM, Gregory PJ, et al. Complementary and alternative medicine for the allergist-immunologist: where do I start? J Allergy Clin Immunol. 2009;123(2):309-316. (Review)
  227. Markham AW, Wilkinson JM. Complementary and alternative medicines (CAM) in the management of asthma: an examination of the evidence. J Asthma. 2004;41(2):131-139. (Systematic review)
  228. Passalacqua G, Bousquet PJ, Carlsen KH, et al. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006;117(5):1054-1062. (Review)
  229. Martin J, Donaldson AN, Villarroel R, et al. Efficacy of acupuncture in asthma: systematic review and meta-analysis of published data from 11 randomised controlled trials. Eur Respir J. 2002;20(4):846-852. (Meta-analysis)
  230. Field T, Henteleff T, Hernandez-Reif M, et al. Children with asthma have improved pulmonary functions after massage therapy. J Pediatr. 1998;132(5):854-858. (Prospective randomized study; 32 patients)
  231. Thomas M, McKinley RK, Mellor S, et al. Breathing exercises for asthma: a randomised controlled trial. Thorax. 2009;64(1):55-61. (Prospective parallel group, single-blind randomized controlled study; 183 patients)
  232. Holloway E, Ram FS. Breathing exercises for asthma. Cochrane Database Syst Rev. 2004. (Systematic review)
  233. Lahmann C, Nickel M, Schuster T, et al. Functional relaxation and guided imagery as complementary therapy in asthma: a randomized controlled clinical trial. Psychother Psychosom. 2009;78(4):233-239. (Prospective cohort; 64 patients)
  234. McKeever TM, Britton J. Diet and asthma. Am J Respir Crit Care Med 2004;170(7):725-729. (Review)
  235. Li XM. Traditional Chinese herbal remedies for asthma and food allergy. J Allergy Clin Immunol. 2007;120(1):25-31. (Review)
  236. Li XM. Complementary and alternative medicine in pediatric allergic disorders. Curr Opin Allergy Clin Immunol. 2009;9(2):161-167. (Review)
  237. Stevens MM, Scribano PV, Gorelick MH. Screening for poor short-term outcome in acute pediatric asthma. Ann Allergy Asthma Immunol. 2007;98(5):432-439. (Prospective cohort; 1221 patients)
  238. Baren JM, Boudreaux ED, Brenner BE, et al. Randomized controlled trial of emergency department interventions to improve primary care follow-up for patients with acute asthma. Chest. 2006;129(2):257-265. (Randomized controlled trial; 384 patients)
  239. Smith SR, Jaffe DM, Fisher EB Jr, et al. Improving follow-up for children with asthma after an acute emergency department visit. J Pediatr. 2004;145(6):772-777. (Prospective randomized study; 527 patients)
  240. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332-336. (Case-control study; 2747 patients)
  241. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343(15):1054-1063. (Randomized controlled trial; 1041 patients)
  242. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107(4):706-711. (Cohort study; 11,195 patients)
  243. Scarfone RJ, Zorc JJ, Angsuco CJ. Emergency physicians’ prescribing of asthma controller medications. Pediatrics. 2006;117(3):821-827. (Survey, 391 participants)
  244. Lehman HK, Lillis KA, Shaha SH, et al. Initiation of maintenance anti-inflammatory medication in asthmatic children in a pediatric emergency department. Pediatrics. 2006;118(6):2394-2401. (Cohort study; 47 patients)
Publication Information
Authors

Brittany Pardue Jones, MD; Audrey Paul, MD, PhD

Publication Date

May 1, 2013

Get Permission

Related Articles

Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.